Optimata Ltd., Developer Of Virtual Patient Biosimulation Technologies, Appoints Dr. David Sidransky To Scientific Board

Optimata Ltd., the developer of Virtual Patient biosimulation technologies, today announced the appointment of Dr. David Sidransky to the company’s scientific board. Dr. Sidransky is a world-renowned cancer researcher and a consultant to a number of leading biotechnology companies. He was named by Time Magazine and CNN as one of America’s top 18 scientists and doctors.

MORE ON THIS TOPIC